These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 23478005)

  • 21. Prognostic significance of T-cell or cytotoxic molecules phenotype in classical Hodgkin's lymphoma: a clinicopathologic study.
    Asano N; Oshiro A; Matsuo K; Kagami Y; Ishida F; Suzuki R; Kinoshita T; Shimoyama Y; Tamaru J; Yoshino T; Kitamura K; Fukutani H; Morishima Y; Nakamura S
    J Clin Oncol; 2006 Oct; 24(28):4626-33. PubMed ID: 16954517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased programmed death-1+ tumor-infiltrating lymphocytes in classical Hodgkin lymphoma substantiate reduced overall survival.
    Muenst S; Hoeller S; Dirnhofer S; Tzankov A
    Hum Pathol; 2009 Dec; 40(12):1715-22. PubMed ID: 19695683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics and outcomes of patients with nodular lymphocyte-predominant Hodgkin lymphoma versus those with classical Hodgkin lymphoma: a population-based analysis.
    Gerber NK; Atoria CL; Elkin EB; Yahalom J
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):76-83. PubMed ID: 25863756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma.
    Martini M; Hohaus S; Petrucci G; Cenci T; Pierconti F; Massini G; Teofili L; Leone G; Larocca LM
    Am J Clin Pathol; 2008 Mar; 129(3):472-7. PubMed ID: 18285272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosis.
    Visco C; Nadali G; Vassilakopoulos TP; Bonfante V; Viviani S; Gianni AM; Federico M; Luminari S; Peethambaram P; Witzig TE; Pangalis G; Cabanillas F; Medeiros LJ; Sarris AH; Pizzolo G
    Eur J Haematol; 2006 Nov; 77(5):387-94. PubMed ID: 16879607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly.
    Wang E; Papavassiliou P; Sebastian S
    Pathol Res Pract; 2012 Jun; 208(6):363-7. PubMed ID: 22572037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphocyte depleted Hodgkin lymphoma: an evaluation with immunophenotyping and genetic analysis.
    Slack GW; Ferry JA; Hasserjian RP; Sohani AR; Longtine JA; Harris NL; Zukerberg LR
    Leuk Lymphoma; 2009 Jun; 50(6):937-43. PubMed ID: 19455461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical expression of vitamin D receptor and forkhead box P3 in classic Hodgkin lymphoma: correlation with clinical and pathologic findings.
    Gupta GK; Agrawal T; Pilichowska M
    BMC Cancer; 2020 Jun; 20(1):535. PubMed ID: 32513132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hodgkin lymphoma involving Waldeyer ring: a clinicopathologic study of 22 cases.
    Quiñones-Avila Mdel P; Gonzalez-Longoria AA; Admirand JH; Medeiros LJ
    Am J Clin Pathol; 2005 May; 123(5):651-6. PubMed ID: 15981804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of pretreatment serum beta-2 microglobulin level in advanced classical Hodgkin lymphoma treated in the modern era.
    Wang Q; Qin Y; Zhou S; He X; Yang J; Kang S; Liu P; Yang S; Zhang C; Gui L; Sun Y; Shi Y
    Oncotarget; 2016 Nov; 7(44):72219-72228. PubMed ID: 27750215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl-2 and MAL expression.
    Kelley TW; Pohlman B; Elson P; Hsi ED
    Am J Clin Pathol; 2007 Dec; 128(6):958-65. PubMed ID: 18024321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The value of CD23 expression as an additional marker in distinguishing mediastinal (thymic) large B-cell lymphoma from Hodgkin lymphoma.
    Salama ME; Rajan Mariappan M; Inamdar K; Tripp SR; Perkins SL
    Int J Surg Pathol; 2010 Apr; 18(2):121-8. PubMed ID: 19223373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical characteristics and prognostic factors of primary extranodal classical Hodgkin lymphoma: a retrospective study.
    Yang M; Ping L; Liu W; Xie Y; Aliya ; Liu Y; Nuersulitan R; Zhu J; Wu M; Song Y
    Hematology; 2019 Dec; 24(1):413-419. PubMed ID: 30922173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hodgkin lymphoma variant of Richter transformation: morphology, Epstein-Barr virus status, clonality, and survival analysis-with comparison to Hodgkin-like lesion.
    Xiao W; Chen WW; Sorbara L; Davies-Hill T; Pittaluga S; Raffeld M; Jaffe ES
    Hum Pathol; 2016 Sep; 55():108-116. PubMed ID: 27184478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease.
    Glavina-Durdov M; Jakic-Razumovic J; Capkun V; Murray P
    Br J Cancer; 2001 May; 84(9):1227-34. PubMed ID: 11336475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome.
    Herling M; Rassidakis GZ; Medeiros LJ; Vassilakopoulos TP; Kliche KO; Nadali G; Viviani S; Bonfante V; Giardini R; Chilosi M; Kittas C; Gianni AM; Bonadonna G; Pizzolo G; Pangalis GA; Cabanillas F; Sarris AH
    Clin Cancer Res; 2003 Jun; 9(6):2114-20. PubMed ID: 12796376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumour-associated mast cells in classical Hodgkin's lymphoma: correlation with histological subtype, other tumour-infiltrating inflammatory cell subsets and outcome.
    Andersen MD; Kamper P; Nielsen PS; Bendix K; Riber-Hansen R; Steiniche T; Hamilton-Dutoit S; Clausen M; d'Amore F
    Eur J Haematol; 2016 Mar; 96(3):252-9. PubMed ID: 25963595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prognostic impact of tumour-associated macrophages and Reed-Sternberg cells in paediatric Hodgkin lymphoma.
    Gupta S; Yeh S; Chami R; Punnett A; Chung C
    Eur J Cancer; 2013 Oct; 49(15):3255-61. PubMed ID: 23791542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphocyte-depleted classic Hodgkin lymphoma with primary extranodal disease: Two cases that highlight the combination of immunodeficiency and immune escape in the pathogenesis.
    Tsuyuki Y; Kohno K; Inagaki Y; Sakai Y; Kosugi H; Takahashi E; Suzuki Y; Shimada S; Kato S; Takahara T; Satou A; Shimoyama Y; Nakamura S; Asano N; Sakakibara A
    J Clin Exp Hematop; 2021; 61(3):173-179. PubMed ID: 34511545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concurrent gastric MALT and Hodgkin lymphoma: a case report.
    Oka K; Nagayama R; Yonekawa N; Nihei T; Sando N; Yatabe Y; Mori N
    Int J Surg Pathol; 2012 Apr; 20(2):201-4. PubMed ID: 21813545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.